Reactive oxygen species (ROS) are identified to control the expression and activity of various essential signaling intermediates involved in cellular proliferation, apoptosis, and differentiation. Indeed, ROS represents a double-edged sword in supporting cell survival and death. Many common pathological processes, including various cancer types and neurodegenerative diseases, are inflammation and oxidative stress triggers, or even initiate them. Keap1-Nrf2 is a master antioxidant pathway in cytoprotective mechanisms through Nrf2 target gene expression. Activation of the Nfr2 pathway benefits cells in the early stages and reduces the level of ROS. In contrast, hyperactivation of Keap1-Nrf2 creates a context that supports the survival of both healthy and cancerous cells, defending them against oxidative stress, chemotherapeutic drugs, and radiotherapy. Considering the dual role of Nrf2 in suppressing or expanding cancer cells, determining its inhibitory/stimulatory position and targeting can represent an impressive role in cancer treatment. This review focused on Nrf2 modulators and their roles in sensitizing breast cancer cells to chemo/radiotherapy agents.

Nrf2 modulation in breast cancer / Ghareghomi, Somayyeh; Habibi-Rezaei, Mehran; Arese, Marzia; Saso, Luciano; Moosavi-Movahedi, Ali Akbar. - In: BIOMEDICINES. - ISSN 2227-9059. - 10:10(2022), p. 2668. [10.3390/biomedicines10102668]

Nrf2 modulation in breast cancer

Arese, Marzia;Saso, Luciano
;
2022

Abstract

Reactive oxygen species (ROS) are identified to control the expression and activity of various essential signaling intermediates involved in cellular proliferation, apoptosis, and differentiation. Indeed, ROS represents a double-edged sword in supporting cell survival and death. Many common pathological processes, including various cancer types and neurodegenerative diseases, are inflammation and oxidative stress triggers, or even initiate them. Keap1-Nrf2 is a master antioxidant pathway in cytoprotective mechanisms through Nrf2 target gene expression. Activation of the Nfr2 pathway benefits cells in the early stages and reduces the level of ROS. In contrast, hyperactivation of Keap1-Nrf2 creates a context that supports the survival of both healthy and cancerous cells, defending them against oxidative stress, chemotherapeutic drugs, and radiotherapy. Considering the dual role of Nrf2 in suppressing or expanding cancer cells, determining its inhibitory/stimulatory position and targeting can represent an impressive role in cancer treatment. This review focused on Nrf2 modulators and their roles in sensitizing breast cancer cells to chemo/radiotherapy agents.
2022
Keap1-Nrf2; Nrf2 inhibitors; antioxidant pathway; breast cancer; oxidative stress
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Nrf2 modulation in breast cancer / Ghareghomi, Somayyeh; Habibi-Rezaei, Mehran; Arese, Marzia; Saso, Luciano; Moosavi-Movahedi, Ali Akbar. - In: BIOMEDICINES. - ISSN 2227-9059. - 10:10(2022), p. 2668. [10.3390/biomedicines10102668]
File allegati a questo prodotto
File Dimensione Formato  
Ghareghomi_Nrf2 Modulation_2022.pdf.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.39 MB
Formato Adobe PDF
1.39 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1658158
Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 36
social impact